SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals
Ranbaxy Laboratories
BSE: 500359|NSE: RANBAXY|ISIN: INE015A01028|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Nov 26, 16:15
615.45
-5.2 (-0.84%)
VOLUME 94,429
LIVE
NSE
Nov 26, 16:15
615.65
-5.5 (-0.89%)
VOLUME 1,001,026
Announcements on Ranbaxy Labs

26th-Nov-2014 11:03Source: BSE

Ranbaxy Labs- Clarification

Ranbaxy Laboratories Ltd had earlier informed to the Stock Exchanges that the Company has filed a complaint against the US FDA in D.C. Federal Court and had also asked the Court for a temporary restra...

26th-Nov-2014 09:28Source: NSE

Ranbaxy Laboratories Limited

Ranbaxy Laboratories Limited has informed the Exchange that the Allotment Committee of Directors at its meeting held on November 25, 2014, allotted 450,000 Equity Shares of Rs.5 each for cash at par t...

26th-Nov-2014 08:34Source: BSE

Ranbaxy Labs- Outcome of Allotment Committee Meeting

Ranbaxy Laboratories Ltd has informed BSE that the Allotment Committee of Directors at its meeting held on November 25, 2014, allotted 450,000 Equity Shares of Rs. 5 each for cash at par to Ranbaxy ES...

21st-Nov-2014 14:29Source: NSE

Ranbaxy Laboratories Limited

The Exchange has sought clarification Ranbaxy Laboratories Limited with respect to recent news item captioned "Ranbaxy fails to block rivals in generic fight". In this regard, Exchange have advised th...

19th-Nov-2014 09:39Source: NSE

Ranbaxy Laboratories Limited

Ranbaxy Laboratories Limited has informed the Exchange regarding the Statement dated November 19, 2014. "Princeton, NJ; Gurgaon, India, November 19, 2014: Following, and in response to, the revocation...

7th-Nov-2014 09:11Source: NSE

Ranbaxy Laboratories Limited

Ranbaxy Laboratories Limited has informed the Exchange regarding the "Statement" dated November 6, 2014 "Ranbaxy Laboratories Limited (Ranbaxy) has received communication from the US FDA".

6th-Nov-2014 16:42Source: BSE

Ranbaxy Labs- Statement

Ranbaxy Laboratories Ltd has submitted to BSE a copy of Statement dated November 06, 2014.

5th-Nov-2014 14:34Source: NSE

Ranbaxy Laboratories Limited

Ranbaxy Laboratories Limited has informed the Exchange regarding a Press Release dated November 5, 2014 titled "Ranbaxy Receives Approval from US FDA to Market Fenofibrate Capsules USP, 43mg and 130mg...

5th-Nov-2014 14:24Source: BSE

Ranbaxy Labs- Ranbaxy receives approval from US FDA to market Fenofibrate Capsules USP, 43 MG and 130 MG

Ranbaxy Laboratories Ltd has informed BSE regarding a Press Release dated November 05, 2014 titled "Ranbaxy receives approval from US FDA to market Fenofibrate Capsules USP, 43 MG and 130 MG".

31st-Oct-2014 20:37Source: NSE

Ranbaxy Laboratories Limited

Ranbaxy Laboratories Limited has informed the Exchange that Company have received a letter on October 31, 2014 from the Luxembourg Stock Exchange (LSE) (where GDS of the Company are listed) intimating...

1 2 3 4 5 Next >>
Quick Links for Ranbaxy Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.